Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Time has come to include Human Papillomavirus (HPV) testing in sperm donor banks.

Depuydt CE, Donders G, Verstraete L, Vanden Broeck D, Beert J, Salembier G, Bosmans E, DhontT N, Van Der Auwera I, Vandenborne K, Ombelet W.

Facts Views Vis Obgyn. 2018 Dec;10(4):201-205.

2.

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.

van Schooneveld E, Wouters MC, Van der Auwera I, Peeters DJ, Wildiers H, Van Dam PA, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ.

Breast Cancer Res. 2012 Feb 21;14(1):R34.

3.

Array-based DNA methylation profiling for breast cancer subtype discrimination.

Van der Auwera I, Yu W, Suo L, Van Neste L, van Dam P, Van Marck EA, Pauwels P, Vermeulen PB, Dirix LY, Van Laere SJ.

PLoS One. 2010 Sep 7;5(9):e12616. doi: 10.1371/journal.pone.0012616.

4.

Generation and therapeutic efficacy of highly oligomer-specific beta-amyloid antibodies.

Hillen H, Barghorn S, Striebinger A, Labkovsky B, Müller R, Nimmrich V, Nolte MW, Perez-Cruz C, van der Auwera I, van Leuven F, van Gaalen M, Bespalov AY, Schoemaker H, Sullivan JP, Ebert U.

J Neurosci. 2010 Aug 4;30(31):10369-79. doi: 10.1523/JNEUROSCI.5721-09.2010.

5.

Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype.

Van der Auwera I, Limame R, van Dam P, Vermeulen PB, Dirix LY, Van Laere SJ.

Br J Cancer. 2010 Aug 10;103(4):532-41. doi: 10.1038/sj.bjc.6605787. Epub 2010 Jul 27.

6.

Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients.

Van der Auwera I, Bovie C, Svensson C, Trinh XB, Limame R, van Dam P, van Laere SJ, van Marck EA, Dirix LY, Vermeulen PB.

BMC Cancer. 2010 Mar 12;10:97. doi: 10.1186/1471-2407-10-97.

7.

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer.

Van der Auwera I, Peeters D, Benoy IH, Elst HJ, Van Laere SJ, Prové A, Maes H, Huget P, van Dam P, Vermeulen PB, Dirix LY.

Br J Cancer. 2010 Jan 19;102(2):276-84. doi: 10.1038/sj.bjc.6605472. Epub 2009 Dec 1.

8.

Quantitative assessment of DNA hypermethylation in the inflammatory and non-inflammatory breast cancer phenotypes.

Van der Auwera I, Bovie C, Svensson C, Limame R, Trinh XB, van Dam P, Van Laere SJ, Van Marck E, Vermeulen PB, Dirix LY.

Cancer Biol Ther. 2009 Dec;8(23):2252-9. Epub 2009 Dec 19.

PMID:
19829046
9.

Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases.

Van den Eynden GG, Van Laere SJ, Van der Auwera I, Trinh XB, Van Marck EA, Dirix LY, Vermeulen PB.

Int J Cancer. 2009 Sep 15;125(6):1494-6. doi: 10.1002/ijc.24524. No abstract available.

10.

The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients.

Van der Auwera I, Elst HJ, Van Laere SJ, Maes H, Huget P, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY.

Br J Cancer. 2009 Apr 21;100(8):1277-86. doi: 10.1038/sj.bjc.6605013.

11.

The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer.

Trinh XB, Tjalma WA, Vermeulen PB, Van den Eynden G, Van der Auwera I, Van Laere SJ, Helleman J, Berns EM, Dirix LY, van Dam PA.

Br J Cancer. 2009 Mar 24;100(6):971-8. doi: 10.1038/sj.bjc.6604921. Epub 2009 Feb 24.

12.

A low frequency of lymph node metastasis in clear-cell renal cell carcinoma is related to low lymphangiogenic activity.

Baldewijns MM, Roskams T, Ballet V, Van den Eynden GG, Van Laere SJ, Van der Auwera I, Lerut E, De Bruïne AP, Thijssen VL, Vermeulen PB, van Poppel H.

BJU Int. 2009 Jun;103(12):1626-31. doi: 10.1111/j.1464-410X.2008.08272.x. Epub 2009 Jan 12.

13.

Relapse-free survival in breast cancer patients is associated with a gene expression signature characteristic for inflammatory breast cancer.

Van Laere S, Beissbarth T, Van der Auwera I, Van den Eynden G, Trinh XB, Elst H, Van Hummelen P, van Dam P, Van Marck E, Vermeulen P, Dirix L.

Clin Cancer Res. 2008 Nov 15;14(22):7452-60. doi: 10.1158/1078-0432.CCR-08-1077.

14.

Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype.

Van der Auwera I, Van Laere SJ, Van den Bosch SM, Van den Eynden GG, Trinh BX, van Dam PA, Colpaert CG, van Engeland M, Van Marck EA, Vermeulen PB, Dirix LY.

Br J Cancer. 2008 Nov 18;99(10):1735-42. doi: 10.1038/sj.bjc.6604705. Epub 2008 Oct 7.

15.

Gene expression profiles associated with the presence of a fibrotic focus and the growth pattern in lymph node-negative breast cancer.

Van den Eynden GG, Smid M, Van Laere SJ, Colpaert CG, Van der Auwera I, Bich TX, van Dam P, den Bakker MA, Dirix LY, Van Marck EA, Vermeulen PB, Foekens JA.

Clin Cancer Res. 2008 May 15;14(10):2944-52. doi: 10.1158/1078-0432.CCR-07-4397.

16.

Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis.

Van Laere S, Van der Auwera I, Van den Eynden G, Van Hummelen P, van Dam P, Van Marck E, Vermeulen PB, Dirix L.

Br J Cancer. 2007 Oct 22;97(8):1165-74. Epub 2007 Sep 11.

17.

Letter to the editor: Lymphangiogenesis in primary breast cancer.

Van den Eynden GG, Van der Auwera I, Colpaert CG, Dirix LY, Van Marck EA, Vermeulen PB.

Cancer Lett. 2007 Oct 28;256(2):279-81; author reply 283-4. Epub 2007 Aug 21. No abstract available.

PMID:
17714860
18.

NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation.

Van Laere SJ, Van der Auwera I, Van den Eynden GG, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY.

Br J Cancer. 2007 Sep 3;97(5):659-69. Epub 2007 Aug 14.

19.

Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer.

Van den Eynden GG, Van der Auwera I, Van Laere SJ, Trinh XB, Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA.

J Pathol. 2007 Sep;213(1):56-64.

PMID:
17674348
20.

Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice.

Muhs A, Hickman DT, Pihlgren M, Chuard N, Giriens V, Meerschman C, van der Auwera I, van Leuven F, Sugawara M, Weingertner MC, Bechinger B, Greferath R, Kolonko N, Nagel-Steger L, Riesner D, Brady RO, Pfeifer A, Nicolau C.

Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9810-5. Epub 2007 May 21.

21.

Differential expression of hypoxia and (lymph)angiogenesis-related genes at different metastatic sites in breast cancer.

Van den Eynden GG, Van Laere SJ, Van der Auwera I, Gilles L, Burn JL, Colpaert C, van Dam P, Van Marck EA, Dirix LY, Vermeulen PB.

Clin Exp Metastasis. 2007;24(1):13-23. Epub 2007 Feb 13.

PMID:
17295094
22.

First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours.

Van der Auwera I, Cao Y, Tille JC, Pepper MS, Jackson DG, Fox SB, Harris AL, Dirix LY, Vermeulen PB.

Br J Cancer. 2006 Dec 18;95(12):1611-25. Epub 2006 Nov 21.

23.

Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer.

Van den Eynden GG, Van der Auwera I, Van Laere SJ, Huygelen V, Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA.

Br J Cancer. 2006 Nov 20;95(10):1362-6. Epub 2006 Oct 31.

24.

Lymphangiogenesis in breast cancer.

Van der Auwera I, Colpaert C, Van Marck E, Vermeulen P, Dirix L.

Am J Surg Pathol. 2006 Aug;30(8):1055-6; author reply 1056-7. No abstract available. Erratum in: Am J Surg Pathol. 2006 Nov;30(11):1488.

PMID:
16861982
25.

Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding.

Van Laere SJ, Van der Auwera I, Van den Eynden GG, Elst HJ, Weyler J, Harris AL, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3249-56.

26.

Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study.

Van den Eynden GG, Van der Auwera I, Van Laere SJ, Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA.

Br J Cancer. 2006 Jun 5;94(11):1643-9.

27.

Neuronal or glial expression of human apolipoprotein e4 affects parenchymal and vascular amyloid pathology differentially in different brain regions of double- and triple-transgenic mice.

Van Dooren T, Muyllaert D, Borghgraef P, Cresens A, Devijver H, Van der Auwera I, Wera S, Dewachter I, Van Leuven F.

Am J Pathol. 2006 Jan;168(1):245-60.

28.

Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study.

Van der Auwera I, Van den Eynden GG, Colpaert CG, Van Laere SJ, van Dam P, Van Marck EA, Dirix LY, Vermeulen PB.

Clin Cancer Res. 2005 Nov 1;11(21):7637-42.

29.

Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.

Van Laere SJ, Van den Eynden GG, Van der Auwera I, Vandenberghe M, van Dam P, Van Marck EA, van Golen KL, Vermeulen PB, Dirix LY.

Breast Cancer Res Treat. 2006 Feb;95(3):243-55. Epub 2005 Oct 27.

30.

Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer.

Van den Eynden GG, Van der Auwera I, Van Laere SJ, Colpaert CG, Turley H, Harris AL, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA.

Br J Cancer. 2005 Nov 14;93(10):1128-36.

31.

Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.

Van den Eynden GG, Van Laere SJ, Van der Auwera I, Merajver SD, Van Marck EA, van Dam P, Vermeulen PB, Dirix LY, van Golen KL.

Breast Cancer Res Treat. 2006 Feb;95(3):219-28. Epub 2005 Oct 22.

32.

A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease.

Van der Auwera I, Wera S, Van Leuven F, Henderson ST.

Nutr Metab (Lond). 2005 Oct 17;2:28.

33.

Preparation of cyclo-phen-type ligands: chelators of metal ions as potential therapeutic agents in the treatment of neurodegenerative diseases.

Boldron C, Van der Auwera I, Deraeve C, Gornitzka H, Wera S, Pitié M, Van Leuven F, Meunier B.

Chembiochem. 2005 Nov;6(11):1976-80. No abstract available.

PMID:
16208731
34.

Virosome-based active immunization targets soluble amyloid species rather than plaques in a transgenic mouse model of Alzheimer's disease.

Zurbriggen R, Amacker M, Kammer AR, Westerfeld N, Borghgraef P, Van Leuven F, Van der Auwera I, Wera S.

J Mol Neurosci. 2005;27(2):157-66.

PMID:
16186626
35.

Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis.

Van Laere S, Van der Auwera I, Van den Eynden GG, Fox SB, Bianchi F, Harris AL, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY.

Breast Cancer Res Treat. 2005 Oct;93(3):237-46.

PMID:
16172796
36.

Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.

Van der Auwera I, Van Laere SJ, Van den Eynden GG, Benoy I, van Dam P, Colpaert CG, Fox SB, Turley H, Harris AL, Van Marck EA, Vermeulen PB, Dirix LY.

Clin Cancer Res. 2004 Dec 1;10(23):7965-71.

37.

Lack of lymphangiogenesis during breast carcinogenesis.

Van der Auwera I, Vermeulen P, Van Marck E, Dirix L.

J Clin Pathol. 2004 Dec;57(12):1342-3. No abstract available.

38.

Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer.

Benoy IH, Elst H, Van der Auwera I, Van Laere S, van Dam P, Van Marck E, Scharpé S, Vermeulen PB, Dirix LY.

Br J Cancer. 2004 Nov 15;91(10):1813-20.

39.

Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice.

Etcheberrigaray R, Tan M, Dewachter I, Kuipéri C, Van der Auwera I, Wera S, Qiao L, Bank B, Nelson TJ, Kozikowski AP, Van Leuven F, Alkon DL.

Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):11141-6. Epub 2004 Jul 19.

40.

Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia.

Stessels F, Van den Eynden G, Van der Auwera I, Salgado R, Van den Heuvel E, Harris AL, Jackson DG, Colpaert CG, van Marck EA, Dirix LY, Vermeulen PB.

Br J Cancer. 2004 Apr 5;90(7):1429-36.

41.

Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer.

Van den Eynden GG, Van der Auwera I, Van Laere S, Colpaert CG, van Dam P, Merajver S, Kleer CG, Harris AL, Van Marck EA, Dirix LY, Vermeulen PB.

Breast Cancer Res Treat. 2004 May;85(1):13-22.

42.

Application of the Fertilase-laser system versus the conventional mechanical method to immobilize spermatozoa for intracytoplasmic sperm injection. A randomized controlled trial.

Debrock S, Spiessens C, Afschrift H, Van der Auwera I, D'Hooghe TM.

Gynecol Obstet Invest. 2003;56(2):102-5. Epub 2003 Aug 25.

PMID:
12937343
43.

A prospective randomized study: day 2 versus day 5 embryo transfer.

Van der Auwera I, Debrock S, Spiessens C, Afschrift H, Bakelants E, Meuleman C, Meeuwis L, D'Hooghe TM.

Hum Reprod. 2002 Jun;17(6):1507-12.

PMID:
12042269
44.

Superovulation of female mice delays embryonic and fetal development.

Van der Auwera I, D'Hooghe T.

Hum Reprod. 2001 Jun;16(6):1237-43.

PMID:
11387298
45.
46.
47.

Male subfertility induced by acute scrotal heating affects embryo quality in normal female mice.

Jannes P, Spiessens C, Van der Auwera I, D'Hooghe T, Verhoeven G, Vanderschueren D.

Hum Reprod. 1998 Feb;13(2):372-5.

PMID:
9557841
48.

Detection of immunoreactive interleukin-11 in human follicular fluid: correlations with ovarian steroid, insulin-like growth factor I levels, and follicular maturity.

Branisteanu I, Pijnenborg R, Spiessens C, Van der Auwera I, Keith JC Jr, Van Assche FA.

Fertil Steril. 1997 Jun;67(6):1054-8.

PMID:
9176443
49.

Sperm functional changes and fertilization in vitro in co-culture with human skin fibroblasts.

Wetzels AM, Van der Auwera I, Bastiaans BA, Goverde HJ, Hollanders HM, Hamilton CJ.

Hum Reprod. 1995 Jan;10(1):137-41.

PMID:
7745043
50.

Supplemental Content

Loading ...
Support Center